
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income | ||||||||||||||||||||||||||
(unaudited, in thousands, except share and per share amounts) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Revenue | $ 281,526 | $ 259,756 | $ 827,189 | $ 810,613 | ||||||||||||||||||||||
Cost of revenue | 156,877 | 146,147 | 449,080 | 455,597 | ||||||||||||||||||||||
Gross profit | 124,649 | 113,609 | 378,109 | 355,016 | ||||||||||||||||||||||
Operating expenses | ||||||||||||||||||||||||||
Research and development | 64,134 | 77,423 | 123,896 | 158,261 | ||||||||||||||||||||||
Sales and marketing | 62,376 | 64,210 | 127,650 | 150,854 | ||||||||||||||||||||||
General and administrative | 29,714 | 33,200 | 57,723 | 59,032 | ||||||||||||||||||||||
Total operating expenses | 156,224 | 174,833 | 309,269 | 368,147 | ||||||||||||||||||||||
Operating (loss) income | (31,575) | (61,224) | 68,840 | (13,131) | ||||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Interest income | 1,911 | 1,973 | 3,260 | 3,834 | ||||||||||||||||||||||
Interest expense | (104) | (109) | (220) | (219) | ||||||||||||||||||||||
Other (expense) income, net | (1,361) | 193 | (941) | (5,836) | ||||||||||||||||||||||
Total other income (expense), net | 446 | 2,057 | 2,099 | (2,221) | ||||||||||||||||||||||
(Loss) income before (benefit from) provision for income taxes | (31,129) | (59,167) | 70,939 | (15,352) | ||||||||||||||||||||||
(Benefit from) provision for income taxes | (2,243) | 10,977 | 6,027 | 4,555 | ||||||||||||||||||||||
Net (loss) income | $ (28,886) | $ (70,144) | $ 64,912 | $ (19,907) | ||||||||||||||||||||||
(Loss) earnings per share: | ||||||||||||||||||||||||||
Basic | $ (0.24) | $ (0.58) | $ 0.54 | $ (0.16) | ||||||||||||||||||||||
Diluted | $ (0.24) | $ (0.58) | $ 0.52 | $ (0.16) | ||||||||||||||||||||||
Weighted-average shares used in computing (loss) earnings per share: | ||||||||||||||||||||||||||
Basic | 120,209,712 | 119,919,163 | 120,349,630 | 120,995,375 | ||||||||||||||||||||||
Diluted | 120,209,712 | 119,919,163 | 123,651,309 | 120,995,375 | ||||||||||||||||||||||
Total comprehensive (loss) income | ||||||||||||||||||||||||||
Net (loss) income | (28,886) | (70,144) | 64,912 | (19,907) | ||||||||||||||||||||||
Change in foreign currency translation adjustment | (1,763) | 656 | (28) | (460) | ||||||||||||||||||||||
Net unrealized loss on marketable securities | (59) | (33) | (42) | (117) | ||||||||||||||||||||||
Comprehensive (loss) income | $ (30,708) | $ (69,521) | $ 64,842 | $ (20,484) | ||||||||||||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||
(unaudited, in thousands, except par values) | ||||||||||||||
As of | ||||||||||||||
March 28, 2026 | September 27, 2025 | |||||||||||||
Assets | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ 200,156 | $ 174,668 | ||||||||||||
Marketable securities | 48,897 | 52,858 | ||||||||||||
Accounts receivable, net | 95,511 | 65,847 | ||||||||||||
Inventories | 160,840 | 171,020 | ||||||||||||
Prepaids and other current assets | 34,718 | 39,642 | ||||||||||||
Total current assets | 540,122 | 504,035 | ||||||||||||
Property and equipment, net | 63,038 | 72,277 | ||||||||||||
Operating lease right-of-use assets | 43,950 | 45,297 | ||||||||||||
Goodwill | 82,854 | 82,854 | ||||||||||||
Intangible assets, net | 67,741 | 75,356 | ||||||||||||
Deferred tax assets | 10,409 | 10,509 | ||||||||||||
Other noncurrent assets | 31,368 | 32,950 | ||||||||||||
Total assets | $ 839,482 | $ 823,278 | ||||||||||||
Liabilities and stockholders’ equity | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ 162,927 | $ 184,109 | ||||||||||||
Accrued expenses | 66,736 | 79,094 | ||||||||||||
Accrued compensation | 24,298 | 21,331 | ||||||||||||
Deferred revenue, current | 38,772 | 21,771 | ||||||||||||
Other current liabilities | 48,374 | 46,107 | ||||||||||||
Total current liabilities | 341,107 | 352,412 | ||||||||||||
Operating lease liabilities, noncurrent | 51,803 | 53,288 | ||||||||||||
Deferred revenue, noncurrent | 59,161 | 59,453 | ||||||||||||
Deferred tax liabilities | 118 | 126 | ||||||||||||
Other noncurrent liabilities | 2,930 | 2,774 | ||||||||||||
Total liabilities | 455,119 | 468,053 | ||||||||||||
Commitments and contingencies | ||||||||||||||
Stockholders’ equity: | ||||||||||||||
Common stock, $0.001 par value | 123 | 123 | ||||||||||||
Treasury stock | (56,653) | (37,398) | ||||||||||||
Additional paid-in capital | 486,326 | 502,775 | ||||||||||||
Accumulated deficit | (47,166) | (112,078) | ||||||||||||
Accumulated other comprehensive income | 1,733 | 1,803 | ||||||||||||
Total stockholders’ equity | 384,363 | 355,225 | ||||||||||||
Total liabilities and stockholders’ equity | $ 839,482 | $ 823,278 | ||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||
Six Months Ended | ||||||||||||||
March 28, 2026 | March 29, 2025 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net income (loss) | $ 64,912 | $ (19,907) | ||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||
Stock-based compensation expense | 30,056 | 45,436 | ||||||||||||
Depreciation and amortization | 25,862 | 32,778 | ||||||||||||
Restructuring and other charges | 848 | 4,889 | ||||||||||||
Provision for excess and obsolete inventory | 343 | (143) | ||||||||||||
Deferred income taxes | 72 | 997 | ||||||||||||
Other | 4,402 | 1,528 | ||||||||||||
Foreign currency transaction loss (gain) | 1,222 | (72) | ||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
Accounts receivable | (31,660) | 4,702 | ||||||||||||
Inventories | 9,837 | 92,615 | ||||||||||||
Other assets | 4,796 | 1,328 | ||||||||||||
Accounts payable and accrued expenses | (33,297) | (83,634) | ||||||||||||
Accrued compensation | 3,522 | 10,456 | ||||||||||||
Deferred revenue | 16,993 | (257) | ||||||||||||
Other liabilities | 25 | 5,791 | ||||||||||||
Net cash provided by operating activities | 97,933 | 96,507 | ||||||||||||
Cash flows from investing activities | ||||||||||||||
Purchases of marketable securities | (25,219) | (25,900) | ||||||||||||
Purchases of property and equipment | (10,734) | (18,662) | ||||||||||||
Maturities of marketable securities | 29,140 | 27,400 | ||||||||||||
Net cash used in investing activities | (6,813) | (17,162) | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Payments for repurchase of common stock | (65,121) | (60,602) | ||||||||||||
Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards | (15,929) | (16,246) | ||||||||||||
Proceeds from exercise of stock options | 15,138 | 2,654 | ||||||||||||
Payments for debt issuance costs | (780) | — | ||||||||||||
Net cash used in financing activities | (66,692) | (74,194) | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 1,060 | (1,725) | ||||||||||||
Net increase in cash and cash equivalents | 25,488 | 3,426 | ||||||||||||
Cash and cash equivalents | ||||||||||||||
Beginning of period | 174,668 | 169,732 | ||||||||||||
End of period | $ 200,156 | $ 173,158 | ||||||||||||
Supplemental disclosure | ||||||||||||||
Cash paid for interest | $ 123 | $ 126 | ||||||||||||
Cash paid for taxes, net of refunds | $ 3,346 | $ 16,493 | ||||||||||||
Cash paid for amounts included in the measurement of lease liabilities, net of tenant improvement reimbursements received | $ 4,473 | $ 1,149 | ||||||||||||
Supplemental disclosure of non-cash investing and financing activities | ||||||||||||||
Purchases of property and equipment in accounts payable and accrued expenses | $ 4,588 | $ 1,311 | ||||||||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | $ 1,829 | $ 1,491 | ||||||||||||
Excise tax on share repurchases, accrued but not paid | $ 130 | $ 264 | ||||||||||||
Reconciliation of GAAP to Non-GAAP Cost of Revenue and Gross Profit | ||||||||||||||||||||||||||
(unaudited, in thousands, except percentages) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Reconciliation of GAAP cost of revenue | ||||||||||||||||||||||||||
GAAP cost of revenue | $ 156,877 | $ 146,147 | $ 449,080 | $ 455,597 | ||||||||||||||||||||||
Stock-based compensation expense | 1,125 | 1,606 | 2,452 | 2,955 | ||||||||||||||||||||||
Amortization of intangibles | 3,144 | 3,144 | 7,525 | 6,474 | ||||||||||||||||||||||
Restructuring and other charges | 664 | 3,935 | 664 | 3,935 | ||||||||||||||||||||||
Non-GAAP cost of revenue | $ 151,944 | $ 137,462 | $ 438,439 | $ 442,233 | ||||||||||||||||||||||
Reconciliation of GAAP gross profit | ||||||||||||||||||||||||||
GAAP gross profit | $ 124,649 | $ 113,609 | $ 378,109 | $ 355,016 | ||||||||||||||||||||||
Stock-based compensation expense | 1,125 | 1,606 | 2,452 | 2,955 | ||||||||||||||||||||||
Amortization of intangibles | 3,144 | 3,144 | 7,525 | 6,474 | ||||||||||||||||||||||
Restructuring and other charges | 664 | 3,935 | 664 | 3,935 | ||||||||||||||||||||||
Non-GAAP gross profit | $ 129,582 | $ 122,294 | $ 388,750 | $ 368,380 | ||||||||||||||||||||||
GAAP gross margin | 44.3% | 43.7% | 45.7% | 43.8% | ||||||||||||||||||||||
Non-GAAP gross margin | 46.0% | 47.1% | 47.0% | 45.4% | ||||||||||||||||||||||
Reconciliation of Selected Non-GAAP Financial Measures | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Research and Development (GAAP) | $ 64,134 | $ 77,423 | $ 123,896 | $ 158,261 | ||||||||||||||||||||||
Stock-based compensation | 5,471 | 8,021 | 11,960 | 21,336 | ||||||||||||||||||||||
Amortization of intangibles | 20 | 18 | 40 | 196 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 857 | 12,766 | 857 | 12,706 | ||||||||||||||||||||||
Research and Development (Non-GAAP) | $ 57,786 | $ 56,618 | $ 111,039 | $ 124,023 | ||||||||||||||||||||||
Sales and Marketing (GAAP) | $ 62,376 | $ 64,210 | $ 127,650 | $ 150,854 | ||||||||||||||||||||||
Stock-based compensation | 2,763 | 3,980 | 5,608 | 9,612 | ||||||||||||||||||||||
Amortization of intangibles | - | - | - | - | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 1,453 | 2,792 | 1,453 | 2,792 | ||||||||||||||||||||||
Sales and Marketing (Non-GAAP) | $ 58,160 | $ 57,438 | $ 120,589 | $ 138,450 | ||||||||||||||||||||||
General and Administrative (GAAP) | 29,714 | 33,200 | 57,723 | 59,032 | ||||||||||||||||||||||
Stock-based compensation | 5,505 | 6,495 | 10,036 | 11,533 | ||||||||||||||||||||||
Legal and transaction related costs | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Amortization of intangibles | 24 | 24 | 48 | 47 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 90 | 4,207 | 90 | 4,207 | ||||||||||||||||||||||
General and Administrative (Non-GAAP) | $ 20,572 | $ 21,045 | $ 41,515 | $ 41,621 | ||||||||||||||||||||||
Total Operating Expenses (GAAP) | $ 156,224 | $ 174,833 | $ 309,269 | $ 368,147 | ||||||||||||||||||||||
Stock-based compensation | 13,739 | 18,496 | 27,604 | 42,481 | ||||||||||||||||||||||
Legal and transaction related costs (1) | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Amortization of intangibles | 44 | 42 | 88 | 243 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 2,400 | 19,765 | 2,400 | 19,705 | ||||||||||||||||||||||
Operating Expenses (Non-GAAP) | $ 136,518 | $ 135,101 | $ 273,143 | $ 304,094 | ||||||||||||||||||||||
Total Operating (Loss) Income (GAAP) | $ (31,575) | $ (61,224) | $ 68,840 | $ (13,131) | ||||||||||||||||||||||
Stock-based compensation | 14,864 | 20,102 | 30,056 | 45,436 | ||||||||||||||||||||||
Legal and transaction related costs (1) | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Amortization of intangibles | 3,188 | 3,186 | 7,613 | 6,717 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 3,064 | 23,700 | 3,064 | 23,640 | ||||||||||||||||||||||
Operating (Loss) Income (Non-GAAP) | $ (6,936) | $ (12,807) | $ 115,607 | $ 64,286 | ||||||||||||||||||||||
Depreciation | 8,653 | 11,981 | 18,249 | 26,061 | ||||||||||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ 1,717 | $ (826) | $ 133,856 | $ 90,347 | ||||||||||||||||||||||
Total Operating (Loss) Income (GAAP) | $ (31,575) | $ (61,224) | $ 68,840 | $ (13,131) | ||||||||||||||||||||||
Stock-based compensation expense | 14,864 | 20,102 | 30,056 | 45,436 | ||||||||||||||||||||||
Legal and transaction related costs (1) | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Amortization of intangibles | 3,188 | 3,186 | 7,613 | 6,717 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 3,064 | 23,700 | 3,064 | 23,640 | ||||||||||||||||||||||
Operating (Loss) Income (Non-GAAP) | $ (6,936) | $ (12,807) | $ 115,607 | $ 64,286 | ||||||||||||||||||||||
Interest income | 1,911 | 1,973 | 3,260 | 3,834 | ||||||||||||||||||||||
Interest expense | (104) | (109) | (220) | (219) | ||||||||||||||||||||||
Pre-tax (Loss) Income (Non-GAAP) | $ (5,129) | $ (10,943) | $ 118,647 | $ 67,901 | ||||||||||||||||||||||
(Benefit from) provision for income taxes | (2,243) | 10,977 | 6,027 | 4,555 | ||||||||||||||||||||||
Net (loss) income (Non-GAAP) | (2,886) | (21,920) | 112,620 | 63,346 | ||||||||||||||||||||||
Weighted-average shares non-GAAP, diluted | 120,209,712 | 119,919,163 | 123,651,309 | 123,750,251 | ||||||||||||||||||||||
Non-GAAP (loss) earnings per share, diluted | $ (0.02) | $ (0.18) | $ 0.91 | $ 0.51 | ||||||||||||||||||||||
(1) Legal and transaction-related costs consist of expenses related to our intellectual property ("IP") litigation against Alphabet and Google, which we do not consider representative of our underlying operating performance. | ||||||||||||||||||||||||||
(2) Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency. | ||||||||||||||||||||||||||
(3) Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards. | ||||||||||||||||||||||||||
Reconciliation of Net (Loss) Income to Adjusted EBITDA | ||||||||||||||||||||||||||
(unaudited, dollars in thousands except percentages) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
(In thousands, except percentages) | ||||||||||||||||||||||||||
Net (loss) income | $ (28,886) | $ (70,144) | $ 64,912 | $ (19,907) | ||||||||||||||||||||||
Add (deduct): | ||||||||||||||||||||||||||
Depreciation and amortization | 11,841 | 15,167 | 25,862 | 32,778 | ||||||||||||||||||||||
Stock-based compensation expense | 14,864 | 20,102 | 30,056 | 45,436 | ||||||||||||||||||||||
Interest income | (1,911) | (1,973) | (3,260) | (3,834) | ||||||||||||||||||||||
Interest expense | 104 | 109 | 220 | 219 | ||||||||||||||||||||||
Other expense (income), net | 1,361 | (193) | 941 | 5,836 | ||||||||||||||||||||||
(Benefit from) provision for income taxes | (2,243) | 10,977 | 6,027 | 4,555 | ||||||||||||||||||||||
Legal and transaction related costs (1) | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 3,064 | 23,700 | 3,064 | 23,640 | ||||||||||||||||||||||
Adjusted EBITDA | $ 1,717 | $ (826) | $ 133,856 | $ 90,347 | ||||||||||||||||||||||
Revenue | $ 281,526 | $ 259,756 | $ 827,189 | $ 810,613 | ||||||||||||||||||||||
Net (loss) income margin | (10.3)% | (27.0)% | 7.8% | (2.5)% | ||||||||||||||||||||||
Adjusted EBITDA margin | 0.6% | (0.3)% | 16.2% | 11.1% | ||||||||||||||||||||||
(1) Legal and transaction-related costs consist of expenses related to our IP litigation against Alphabet and Google, which we do not consider representative of our underlying operating performance. | ||||||||||||||||||||||||||
(2) Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency. | ||||||||||||||||||||||||||
(3) Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards. | ||||||||||||||||||||||||||
Reconciliation of GAAP Net (Loss) Income to Non-GAAP Net (Loss) Income | ||||||||||||||||||||||||||
(unaudited, in thousands, except share and per share amounts) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
GAAP net (loss) income | $ (28,886) | $ (70,144) | $ 64,912 | $ (19,907) | ||||||||||||||||||||||
Stock-based compensation expense | 14,864 | 20,102 | 30,056 | 45,436 | ||||||||||||||||||||||
Legal and transaction related costs (1) | 3,523 | 1,429 | 6,034 | 1,624 | ||||||||||||||||||||||
Amortization of intangibles | 3,188 | 3,186 | 7,613 | 6,717 | ||||||||||||||||||||||
Restructuring and other charges (2)(3) | 3,064 | 23,700 | 3,064 | 23,640 | ||||||||||||||||||||||
Other expense (income), net | 1,361 | (193) | 941 | 5,836 | ||||||||||||||||||||||
Non-GAAP net (loss) income | $ (2,886) | $ (21,920) | $ 112,620 | $ 63,346 | ||||||||||||||||||||||
(Loss) earnings per share | ||||||||||||||||||||||||||
GAAP (loss) earnings per share, diluted | $ (0.24) | $ (0.58) | $ 0.52 | $ (0.16) | ||||||||||||||||||||||
Non-GAAP (loss) earnings per share, diluted | $ (0.02) | $ (0.18) | $ 0.91 | $ 0.51 | ||||||||||||||||||||||
Shares used to calculate (loss) earnings per share | ||||||||||||||||||||||||||
Weighted-average shares GAAP, diluted | 120,209,712 | 119,919,163 | 123,651,309 | 120,995,375 | ||||||||||||||||||||||
Weighted-average shares non-GAAP, diluted | 120,209,712 | 119,919,163 | 123,651,309 | 123,750,251 | ||||||||||||||||||||||
(1) Legal and transaction-related costs consist of expenses related to our IP litigation against Alphabet and Google, which we do not consider representative of our underlying operating performance. | ||||||||||||||||||||||||||
(2) Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency. | ||||||||||||||||||||||||||
(3) Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards. | ||||||||||||||||||||||||||
Reconciliation of Cash Flows (Used in) Provided by Operating Activities to Free Cash Flow | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Cash flows (used in) provided by operating activities | $ (65,374) | $ (59,666) | $ 97,933 | $ 96,507 | ||||||||||||||||||||||
Less: Purchases of property and equipment | (4,776) | (5,556) | (10,734) | (18,662) | ||||||||||||||||||||||
Free cash flow | $ (70,150) | $ (65,222) | $ 87,199 | $ 77,845 | ||||||||||||||||||||||
Revenue by Product Category | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Sonos speakers | $ 210,018 | $ 194,519 | $ 669,258 | $ 661,661 | ||||||||||||||||||||||
Sonos system products | 52,411 | 50,540 | 117,469 | 110,814 | ||||||||||||||||||||||
Partner products and other revenue | 19,097 | 14,697 | 40,462 | 38,138 | ||||||||||||||||||||||
Total revenue | $ 281,526 | $ 259,756 | $ 827,189 | $ 810,613 | ||||||||||||||||||||||
Revenue by Geographical Region | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Americas | $ 180,608 | $ 176,802 | $ 509,485 | $ 501,385 | ||||||||||||||||||||||
Europe, Middle East and Africa | 83,161 | 68,785 | 272,602 | 266,397 | ||||||||||||||||||||||
Asia Pacific | 17,757 | 14,169 | 45,102 | 42,831 | ||||||||||||||||||||||
Total revenue | $ 281,526 | $ 259,756 | $ 827,189 | $ 810,613 | ||||||||||||||||||||||
Stock-based Compensation | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Cost of revenue | $ 1,125 | $ 1,606 | $ 2,452 | $ 2,955 | ||||||||||||||||||||||
Research and development | 5,471 | 8,557 | 11,960 | 21,872 | ||||||||||||||||||||||
Sales and marketing | 2,763 | 4,027 | 5,608 | 9,659 | ||||||||||||||||||||||
General and administrative | 5,505 | 9,055 | 10,036 | 14,093 | ||||||||||||||||||||||
Total stock-based compensation expense | $ 14,864 | $ 23,245 | $ 30,056 | $ 48,579 | ||||||||||||||||||||||
Amortization of Intangibles | ||||||||||||||||||||||||||
(unaudited, dollars in thousands) | ||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | |||||||||||||||||||||||
Cost of revenue | $ 3,144 | $ 3,144 | $ 7,525 | $ 6,474 | ||||||||||||||||||||||
Research and development | 20 | 18 | 40 | 196 | ||||||||||||||||||||||
Sales and marketing | - | - | - | - | ||||||||||||||||||||||
General and administrative | 24 | 24 | 48 | 47 | ||||||||||||||||||||||
Total amortization of intangibles | $ 3,188 | $ 3,186 | $ 7,613 | $ 6,717 | ||||||||||||||||||||||